Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Evotooth Platinum Sdn Bhd is currently managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is handled by 1 distinct examiner and 1 distinct art unit. This configuration indicates a highly focused prosecution environment where a single reviewer in one specialized group is evaluating the company's current application.
FUBARA, BLESSING M is the busiest examiner for the company. This examiner is responsible for the 1 pending office action currently active. Because the entire active portfolio consists of this single matter, the company's current progress is tied directly to the feedback from this specific examiner. This concentration simplifies the administrative management of the portfolio.
The 1 distinct art unit involved indicates a specific technical focus within the Biotechnology & Pharmaceuticals sector. The 1 pending office action assigned to FUBARA, BLESSING M represents the total current workload for the company at the patent office. Practitioners should focus on the specific examination history of this examiner to navigate the current prosecution effectively.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FUBARA, BLESSING M | 1 | 62.2% | +34.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18723601 | ORAL CARE COMPOSITION | FUBARA, BLESSING M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18723601 | ORAL CARE COMPOSITION | FUBARA, BLESSING M | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18723601 | ORAL CARE COMPOSITION | FUBARA, BLESSING M | 1613 | §103§112 | Final Rejection | — | Pending | Jun 24, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialEvotooth Platinum Sdn Bhd has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Blessing M Fubara has the most, with 1 of Evotooth Platinum Sdn Bhd's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
